APREPITANT in English translation

Examples of using Aprepitant in Slovenian and their translations into English

Style/topic:

Zdravilna učinkovina je aprepitant. Ena kapsula vsebuje 165 mg aprepitanta.

The active substance is aprepitant. Each capsule contains 165 mg of aprepitant..

Razlika(%) izračunana kot aprepitant 40 mg minus ondansetron 4 mg.

Difference(%) calculated as Aprepitant 40 mg minus Ondansetron 4 mg.

Preobčutljivost za zdravilno učinkovino, aprepitant, polisorbat 80 ali katerokoli pomožno snov.

Hypersensitivity to the active substance, aprepitant, or to polysorbate 80 or any of the other excipients.

Emend(aprepitant)- Pogoji

Emend(aprepitant)- Conditions

Fosaprepitant, predzdravilo aprepitanta, se po intravenski aplikaciji hitro pretvori v aprepitant.

Fosaprepitant, a prodrug of aprepitant, when administered intravenously is rapidly converted to aprepitant.

Zdravilo Ivemend vsebuje snov, imenovano fosaprepitant, ki se v telesu pretvori v aprepitant.

Ivemend contains a substance called fosaprepitant which is converted in the body into aprepitant.

V kliničnih študijah medsebojnega delovanja aprepitant ni imel klinično pomembnih učinkov na farmakokinetiko granisetrona.

In clinical interaction studies, aprepitant did not have clinically important effects on the pharmacokinetics of granisetron.

do katerih sicer pride pri kemoterapiji- aprepitant.

vomiting associated with chemotherapy- aprepitant.

Pri pretvorbi 115 mg fosaprepitanta v aprepitant se iz fosaprepitanta sprosti 18, 3 mg fosfata.

Upon conversion of 115 mg of fosaprepitant to aprepitant, 18.3 mg of phosphate is liberated from fosaprepitant.

se uporabljajo za zdravljenje siljenja na bruhanje in bruhanja(npr. aprepitant);

help treat nausea and vomiting(such as aprepitant);

Zdravila, ki vsebujejo aprepitant, so v Evropski uniji na voljo od leta 2003 pod imenom EMEND.

Medicines containing aprepitant have been available in the European Union as EMEND since 2003.

Pri pediatričnih bolnikih, ki so prejemali aprepitant, je bilo potrebno zmanjšanje(50%) odmerka deksametazona.

A dose reduction(50%) of dexamethasone was required for paediatric patients receiving aprepitant.

Za fosaprepitant in aprepitant ni na voljo kliničnih podatkov od nosečnic, ki so bile izpostavljene zdravilu.

For fosaprepitant and aprepitant no clinical data on exposed pregnancies are available.

Aprepitant se izloča v mleko podgan.

Aprepitant is excreted in the milk of lactating rats.

Kaže, da aprepitant ne vstopa v interakcije z digoksinom, kar nakazuje, da nima interakcij s P-glikoproteinskim prenašalcem.

Aprepitant does not seem to interact with the P-glycoprotein transporter, as suggested by the lack of interaction of aprepitant with digoxin.

Aprepitant se ne izloča nespremenjen z urinom.

Aprepitant is not excreted unchanged in urine.

Aprepitant se močno veže na beljakovine, povprečno 97-odstotno.

Aprepitant is highly protein bound, with a mean of 97%.

Aprepitant je antagonist receptorjev za nevrokinin 1(NK1).

Aprepitant is a neurokinin 1(NK1) receptor antagonist.

Aprepitant se močno veže na beljakovine, povprečno 97%.

Aprepitant is highly protein bound, with a mean of 97%.

Aprepitant se ne izloča z urinom v nespremenjeni obliki.

Aprepitant is not excreted unchanged in urine.